Femovate

Femovate is a global femtech incubator and venture studio established in 2022. It invests design capital in early-stage women's health startups to enhance product development and market launch. With over 70 portfolio companies, Femovate has invested more than $2 million, enabling the launch of 30 products and helping startups raise over $130 million in funding. The company focuses on advancing women's health innovation across various sectors, including femtech, biotech, and digital health. It offers comprehensive support in areas such as product market fit, go-to-market strategies, and female-centric design. Femovate also creates digital prototypes and vision demos to prepare startups for investment. Its expertise covers a wide range of product types, including software as a medical device and consumer digital health solutions. The team, led by founder Theresa Neil, has extensive experience in the healthcare industry, having worked with major organizations and conducted significant research in women's health.